Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy

BackgroundAcute hematologic toxicity (HT) is a common complication during radiotherapy of cervical cancer which may lead to treatment delay or interruption. Despite the use of intensity-modulated radiation therapy (IMRT) with the pelvic bone marrow (PBM) sparing, some patients still suffer from acut...

Full description

Bibliographic Details
Main Authors: Xiangdi Meng, Nan Wang, Meng Yu, Dechen Kong, Zhengtao Zhang, Xiaolong Chang, Yinghua Guo, Yang Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.993443/full
_version_ 1811274254673510400
author Xiangdi Meng
Nan Wang
Meng Yu
Dechen Kong
Zhengtao Zhang
Xiaolong Chang
Yinghua Guo
Yang Li
author_facet Xiangdi Meng
Nan Wang
Meng Yu
Dechen Kong
Zhengtao Zhang
Xiaolong Chang
Yinghua Guo
Yang Li
author_sort Xiangdi Meng
collection DOAJ
description BackgroundAcute hematologic toxicity (HT) is a common complication during radiotherapy of cervical cancer which may lead to treatment delay or interruption. Despite the use of intensity-modulated radiation therapy (IMRT) with the pelvic bone marrow (PBM) sparing, some patients still suffer from acute HT. We aimed to identify predictors associated with HT and develop a nomogram for predicting grade 2 or higher (G2+) acute HT in cervical cancer following the PBM sparing strategy.MethodsThis study retrospectively analyzed 125 patients with cervical cancer who underwent IMRT with the PBM sparing strategy at our institution. Univariate and multivariate logistic regression, best subset regression, and least absolute shrinkage and selection operator (LASSO) regression, respectively, were used for predictor screening, and Akaike information criterion (AIC) was used to determine the best model for developing the nomogram. Finally, we quantified the risk of G2+ acute HT based on this model to establish a risk stratification.ResultsThe independent predictors used to develop the nomogram were histological grade, pre-radiotherapy chemotherapy, pre-radiotherapy HT, and radiotherapy [IMRT alone vs. concurrent chemoradiotherapy (CCRT)] which were determined by the univariate and multivariate logistic regression with the minimum AIC of 125.49. Meanwhile, the heat map showed that there is no multicollinearity among the predictors. The nomogram was well-calibrated to reality, with a Brier score of 0.15. The AUC value was 0.82, and the median Brier score and AUC in 1000 five-fold cross-validation were 0.16 and 0.80, respectively. The web version developed together was very easy to use. The risk stratification indicated that high-risk patients (risk point > 195.67) were more likely to develop G2+ acute HT [odds ratio (OR) = 2.17, 95% confidence interval (CI): 1.30–3.05].ConclusionThis nomogram well-predicted the risk of G2+ acute HT during IMRT in cervical cancer after the PBM sparing strategy, and the constructed risk stratification could assist physicians in screening high-risk patients and provide a useful reference for future prevention and treatment strategies for acute HT.
first_indexed 2024-04-12T23:15:41Z
format Article
id doaj.art-06921b08fb53411886019e9fe60d00c3
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-12T23:15:41Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-06921b08fb53411886019e9fe60d00c32022-12-22T03:12:40ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-09-011010.3389/fpubh.2022.993443993443Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapyXiangdi Meng0Nan Wang1Meng Yu2Dechen Kong3Zhengtao Zhang4Xiaolong Chang5Yinghua Guo6Yang Li7Department of Radiation Oncology, Weifang People's Hospital, Weifang, ChinaDepartment of Radiation Oncology, Weifang People's Hospital, Weifang, ChinaDepartment of Radiation Oncology, Weifang People's Hospital, Weifang, ChinaClinical School, Weifang Medical University, Weifang, ChinaClinical School, Weifang Medical University, Weifang, ChinaDepartment of Radiation Oncology, Weifang People's Hospital, Weifang, ChinaDepartment of Radiation Oncology, Weifang People's Hospital, Weifang, ChinaDepartment of Radiation Oncology, Weifang People's Hospital, Weifang, ChinaBackgroundAcute hematologic toxicity (HT) is a common complication during radiotherapy of cervical cancer which may lead to treatment delay or interruption. Despite the use of intensity-modulated radiation therapy (IMRT) with the pelvic bone marrow (PBM) sparing, some patients still suffer from acute HT. We aimed to identify predictors associated with HT and develop a nomogram for predicting grade 2 or higher (G2+) acute HT in cervical cancer following the PBM sparing strategy.MethodsThis study retrospectively analyzed 125 patients with cervical cancer who underwent IMRT with the PBM sparing strategy at our institution. Univariate and multivariate logistic regression, best subset regression, and least absolute shrinkage and selection operator (LASSO) regression, respectively, were used for predictor screening, and Akaike information criterion (AIC) was used to determine the best model for developing the nomogram. Finally, we quantified the risk of G2+ acute HT based on this model to establish a risk stratification.ResultsThe independent predictors used to develop the nomogram were histological grade, pre-radiotherapy chemotherapy, pre-radiotherapy HT, and radiotherapy [IMRT alone vs. concurrent chemoradiotherapy (CCRT)] which were determined by the univariate and multivariate logistic regression with the minimum AIC of 125.49. Meanwhile, the heat map showed that there is no multicollinearity among the predictors. The nomogram was well-calibrated to reality, with a Brier score of 0.15. The AUC value was 0.82, and the median Brier score and AUC in 1000 five-fold cross-validation were 0.16 and 0.80, respectively. The web version developed together was very easy to use. The risk stratification indicated that high-risk patients (risk point > 195.67) were more likely to develop G2+ acute HT [odds ratio (OR) = 2.17, 95% confidence interval (CI): 1.30–3.05].ConclusionThis nomogram well-predicted the risk of G2+ acute HT during IMRT in cervical cancer after the PBM sparing strategy, and the constructed risk stratification could assist physicians in screening high-risk patients and provide a useful reference for future prevention and treatment strategies for acute HT.https://www.frontiersin.org/articles/10.3389/fpubh.2022.993443/fullcervical cancerintensity-modulated radiation therapynomogramhematologic toxicityrisk stratification
spellingShingle Xiangdi Meng
Nan Wang
Meng Yu
Dechen Kong
Zhengtao Zhang
Xiaolong Chang
Yinghua Guo
Yang Li
Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy
Frontiers in Public Health
cervical cancer
intensity-modulated radiation therapy
nomogram
hematologic toxicity
risk stratification
title Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy
title_full Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy
title_fullStr Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy
title_full_unstemmed Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy
title_short Development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy
title_sort development of a nomogram for predicting grade 2 or higher acute hematologic toxicity of cervical cancer after the pelvic bone marrow sparing radiotherapy
topic cervical cancer
intensity-modulated radiation therapy
nomogram
hematologic toxicity
risk stratification
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.993443/full
work_keys_str_mv AT xiangdimeng developmentofanomogramforpredictinggrade2orhigheracutehematologictoxicityofcervicalcancerafterthepelvicbonemarrowsparingradiotherapy
AT nanwang developmentofanomogramforpredictinggrade2orhigheracutehematologictoxicityofcervicalcancerafterthepelvicbonemarrowsparingradiotherapy
AT mengyu developmentofanomogramforpredictinggrade2orhigheracutehematologictoxicityofcervicalcancerafterthepelvicbonemarrowsparingradiotherapy
AT dechenkong developmentofanomogramforpredictinggrade2orhigheracutehematologictoxicityofcervicalcancerafterthepelvicbonemarrowsparingradiotherapy
AT zhengtaozhang developmentofanomogramforpredictinggrade2orhigheracutehematologictoxicityofcervicalcancerafterthepelvicbonemarrowsparingradiotherapy
AT xiaolongchang developmentofanomogramforpredictinggrade2orhigheracutehematologictoxicityofcervicalcancerafterthepelvicbonemarrowsparingradiotherapy
AT yinghuaguo developmentofanomogramforpredictinggrade2orhigheracutehematologictoxicityofcervicalcancerafterthepelvicbonemarrowsparingradiotherapy
AT yangli developmentofanomogramforpredictinggrade2orhigheracutehematologictoxicityofcervicalcancerafterthepelvicbonemarrowsparingradiotherapy